MedTrace Logo

ACtive Catheterization for EndovaScular TreatmentS

NCT05355259 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-11-03

No results posted yet for this study

Summary

The objective of this clinical investigation is to evaluate the safety and technical success of the Basecamp Vascular controllable directional GECKO guidewire when used to facilitate endovascular access to the targeted vessel in order to treat the vascular lesion.

Conditions

  • Unruptured Intracranial Aneurysm
  • Arteriovenous Cerebral Malformations
  • Carotid Stenosis

Interventions

DEVICE

GECKO Active Guidewire

The GECKO device is intended to introduce devices used for treatment, at a desired anatomical location (cervical carotid artery, for example) in the central circulatory system. The GECKO guidewire itself is not meant to perform a treatment but is used to set the primary access that will allow performance of the treatments.

Sponsors & Collaborators

  • Basecamp Vascular

    lead INDUSTRY

Principal Investigators

  • Michel Piotin, M.D. · Fondation Ophtalmologique Adolphe de Rothschild

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-27
Primary Completion
2022-08-05
Completion
2022-08-05

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05355259 on ClinicalTrials.gov